Update

Get An Update on Antibiotics on CME Webcast

by

OSUWexnerbloglogo2014 Get An Update on Antibiotics on CME Webcast. Today on OSU MedNet, we are going to update you on some of these new antibiotics. Let me welcome today’s guest, Dr. Sydney Agnello. She is an infectious disease expert and Assistant Professor of Internal Medicine from the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: enhance knowledge of clinical use of well-known antibiotics; and enhance understanding of newer antibiotics available and when they may be used clinically.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Provides Asthma Update

by

OSUWexnerbloglogo2014 CME Webcast Provides Asthma Update. To update us on the latest in asthma treatments, we’re pleased to welcome two of the Ohio State University’s top asthma specialists. Dr. Megan Conroy is a pulmonologist and Assistant Professor of Internal Medicine. And Dr. Gennie Wang is also an Assistant Professor of Internal Medicine from the Division of Pulmonary and Critical Care Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe outcomes in asthma patients with COVID- 19; apply updated evidence and guideline recommendations in the management of mild asthma, with a focus on SMART therapy; and differentiate between difficult-to-treat asthma from severe asthma, and understand the significance of asthma phenotypes and their implications in the treatment of severe asthma.

You’ll also learn about the following:

  • New directions in inhaler use
  • New biologic agents
  • Asthma and allergies
  • How interchangeable are inhaled steroid and bronchodilator brands

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get Anticoagulant and Antiplatelet Update from CME Webcast

by

OSUWexnerbloglogo2014 Get Anticoagulant and Antiplatelet Update from CME Webcast. We now have many new anticoagulant and antiplatelet drugs for physicians to choose from but more choices means that it can be harder to select the best drug for any given clinical situation. On this CME webcast, we are going to help you pick the best anticoagulant and the best antiplatelet for your patients. We’re pleased to welcome two anticoagulation experts from the Ohio State University. Tiffany Ortman is a clinical pharmacist who will be updating us about anticoagulants. And Danielle Blais is also a clinical pharmacist who will be updating us about antiplatelets.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DETERMINE optimal oral anticoagulant based on patient-specific characteristics; RECOMMENDED monitoring for direct oral anticoagulants; DESCRIBE the role of aspirin and oral P2Y12 inhibitors for patients with stable ischemic heart disease or acute coronary syndromes with or without percutaneous coronary intervention; and EVALUATE the advantages and disadvantages of the different P2Y12 inhibitors.

You’ll also learn about the following:

  • The spectrum of anticoagulants
  • New anti-platelet drugs
  • Direct oral anticoagulant costs and insurance coverage
  • Home INR monitoring

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Provide An Update on Treatment of COVID-19

by

OSUWexnerbloglogo2014 Experts Provide An Update on Treatment of COVID-19. The pandemic is bad now but it is projected to get even worse over the next months. Many physicians, nurse practitioners, and physician assistants are going to be called on to care for patients with COVID-19 and we want to be sure that you have to tools you need to provide the best possible care for your patients. On this CME webcast, welcome back to MedNet21 two veteran presenters about the COVID-19 outbreak. Dr. Michael Haden is an Assistant Professor of Internal Medicine from the Division of Infectious Disease at the Ohio State University. And Dr. Rachel Quaney is a pulmonologist and Clinical Instructor of Internal Medicine at Ohio State.


What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW infection control measures necessary regarding SARS-CoV-2; PROVIDE update on current treatment recommendations for COVID-19; EVALUATE a patient with respiratory failure from COVID-19; and DISCUSS the risk factors for SARS-CoV-2 transmission as well as the risk factors for severe COVID-19.

You’ll also learn about the following:

  • Improvements in the treatment of COVID-19
  • Changes in the ICU management of COVID-19
  • COVID-19 vaccine safety

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Provides An Update on COPD

by

OSUWexnerbloglogo2014 CME Webcast Provides An Update on COPD. This webcast will give you opportunity learn a great deal about COPD from an our expert that manages it on a regular basis.

 

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Diagnose and classify COPD; Prescribe step-wise treatment for management of stable COPD; Identify patients who would benefit by home oxygen; Manage COPD exacerbations; and Develop strategies to reduce re-admissions for COPD.

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.